The role of stem cell transplantation in multiple myeloma

This publication has 44 references indexed in Scilit:

• Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
  Blood, 2002
• A combination of anti‐interleukin 6 murine monoclonal antibody with dexamethasone and high‐dose melphalan induces high complete response rates in advanced multiple myeloma
  British Journal of Haematology, 2000
• Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients
  Blood, 1999
• Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma
  Bone Marrow Transplantation, 1999
• High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial
  Blood, 1998
• Multiple Myeloma
  New England Journal of Medicine, 1997
• High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
  Annals of Oncology, 1997
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
  New England Journal of Medicine, 1996
• Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
  Journal of Clinical Oncology, 1996
• High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
  Blood, 1987